TARGETING THE B-CELL RECEPTOR PATHWAY: THE CLINICAL SIGNIFICANCE IN CLL

被引：0
|
作者：
Kotsianidis, Ioannis [1 ,2 ]
机构：
[1] Democritus Univ Thrace, Hematol, Alexandroupolis, Greece
[2] Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece
来源：
LEUKEMIA RESEARCH | 2016年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-29
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [31] Venetoclax is an option in B-cell prolymphocytic leukaemia following progression on B-cell receptor pathway inhibitors
    Patil, Nikila
    Went, Richard G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (04) : E80 - E82
  • [32] T-CELL DETERMINANTS IN B-CELL CLL
    KANTER, RJ
    STEINBERG, J
    RAI, K
    CALHOON, RE
    SAWITSKY, A
    CLINICAL RESEARCH, 1982, 30 (02): : A351 - A351
  • [33] Premonoclonal B-cell lymphocytosis: the CLL cell of origin
    Marti, Gerald
    BLOOD, 2022, 139 (10) : 1436 - 1437
  • [34] Impact of Venetoclax on the Quality of Life of CLL Patients Relapsed/Refractory to B-Cell Receptor (BCR) Signaling Pathway Inhibitor Treatment
    Wierda, W.
    Sail, K.
    Potluri, J.
    Noe, L.
    Kamalakar, R.
    Gdovin, J.
    Humerickhouse, R.
    Verdugo, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 88 - 89
  • [35] IMPACT OF VENETOCLAX ON THE QUALITY OF LIFE OF CLL PATIENTS RELAPSED/REFRACTORY TO B-CELL RECEPTOR (BCR) SIGNALING PATHWAY INHIBITOR TREATMENT
    Wierda, W.
    Sail, K.
    Potluri, J.
    Noe, L.
    Kamalakar, R.
    Gdovin, J.
    Humerickhouse, R.
    Verdugo, M.
    HAEMATOLOGICA, 2017, 102 : 295 - 295
  • [36] B Cell Receptor and Antigens in CLL
    Agathangelidis, Andreas
    Ntoufa, Stavroula
    Stamatopoulos, Kostas
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 1 - 24
  • [37] B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs - a Novel Treatment Approach for B-Cell Lymphomas
    Bewarder, Moritz
    Thurner, Lorenz
    Preuss, Klaus Dieter
    Regitz, Evi
    Fadle, Natalie
    Pfreundschuh, Michael
    BLOOD, 2017, 130
  • [38] Targeting the B cell receptor pathway in chronic lymphocytic leukemia
    Davids, Matthew S.
    Brown, Jennifer R.
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2362 - 2370
  • [39] Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
    Xu, Wendan
    Berning, Philipp
    Lenz, Georg
    BLOOD, 2021, 138 (13) : 1110 - 1119
  • [40] Concurrent treatment with two B-cell receptor pathway inhibitors
    Robak, Tadeusz
    LANCET HAEMATOLOGY, 2019, 6 (01): : E8 - E9
12345